Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children
Madison, WI. Jan 31, 2019 – Invenra and WARF (Wisconsin Alumni Research Foundation) today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, a cancer that is the third most...
With New Cash and Facilities, Phoenix Transitions Out Of Startup Mode
It’s often not obvious precisely when an early-stage business reaches the point where it outgrows the “startup” label. Case in point: Madison, WI-based Phoenix, which sells neutron generators and provides image-reading services to organizations in industries ranging...
Wisconsin venture capital funding up 90% in 2018
Wisconsin startup investors were very active in 2018, driving a 90 percent increase in venture capital funding from 2017, according to a new report from Pitchbook and the National Venture Capital Association. Read more here: BizTimes
Best of Madison Business 2019: Leaders with 20/20
On the cusp of 2020, a date many have actually targeted for more than 20 years as a benchmark of Madison’s growth as a region, our business sector is ready for its close-up. As we report in some detail in our cover story this month, the Madison business community has...
From poet and ski bum to disease fighter: Roland Green
JUDY NEWMAN jdnewman@madison.com Dec 2, 2018 CEO Roland Green, left, talks with scientist Daniel Gerhardt at Invenra's labs, 505 S. Rosa Road, where researchers are developing cancer-fighting drugs. Green majored in English literature then switched to environmental...
SHINE and Deerfield Close $150 Million Financing
SHINE and Deerfield Close $150 Million Financing SHINE AND DEERFIELD CLOSE $150 MILLION FINANCING COMMITMENT TO SUPPORT DIAGNOSTIC AND THERAPEUTIC MEDICAL ISOTOPE MANUFACTURING November 27, 2018 – New York, NY and Janesville, WI – SHINE Medical Technologies Inc....
FluGen brings in more money to get ready for more studies of its universal flu vaccine
JUDY NEWMAN jdnewman@madison.com Nov 25, 2018 Research scientist David Marshall, left, and senior scientist Mike Moser look at cells being grown for studies of an experimental flu vaccine at FluGen. AMBER ARNOLD, STATE JOURNAL ARCHIVES FluGen is just finishing one...
Phoenix Delivers First Production Accelerator
Phoenix Delivers First Production Accelerator SHINE On Path to Become Leading Domestic Producer of Mo-99 Photo: SHINE CEO, Greg Piefer, standing with parts of the Phoenix first production unit accelerator, delivered to SHINE Building One on Monday. October 18th, 2018...
Invenra Secures $7M in Series B Growth Round to Accelerate Bispecific Antibody Development
MADISON, Wis. – October 17, 2018 – Invenra, an antibody drug discovery and development company with novel multispecific platforms and product candidates, announced the close of a $7M Series B financing round. The financing will be used to expand the company to meet...
Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns
Jeff Buchanan October 16th, 2018 @_jeffbuchanan @xconomy Like Us Xconomy Wisconsin — An agency within the U.S. Department of Health and Human Services has awarded Stratatech, a Madison, WI-based maker of human skin tissue, $26 million in new funding. Stratatech, which...